IR@PKUHSC  > 北京大学临床肿瘤学院
学科主题临床医学
Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status
Xu, Y; Yao, LH; Li, HX; Tao, OY; Li, JF; Wang, TF; Fan, ZQ; Lin, BY; Lu, YY; Larsson, O; Xie, YT
关键词breast cancer erbB2 mRNA plasma
刊名BREAST CANCER RESEARCH AND TREATMENT
2006-05-01
DOI10.1007/s10549-005-9086-7
97期:1页:49-55
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
关键词[WOS]PERIPHERAL-BLOOD ; PROGNOSTIC VALUE ; NUCLEIC-ACIDS ; LUNG-CANCER ; MARKER ; MAMMAGLOBIN ; EXPRESSION ; DIAGNOSIS ; SURVIVAL ; DISEASE
英文摘要

Several studies have demonstrated that tumor cell-derived RNA is presented in the plasma from breast cancer patients. However, no studies have focused on the detection of plasma erbB2 mRNA in breast cancer. In this study the expression of erbB2 mRNA in the plasma was analyzed in 106 breast cancer patients and 50 healthy subjects by using a nested RT-PCR strategy, and the circulating tumor cells were also detected by using a nested RT-PCR for detection of mammaglobin transcripts in the peripheral blood. Plasma erbB2 mRNA was detectable in 46 (43.3%) breast cancer patients, whereas only 5 normal subjects (10%) were positive in the control group (p=0.001). The presence of erbB2 mRNA in the plasma was not associated with menopausal status, erbB2 expression in primary tumor tissues, tumor size, histological grade, Ki-67 expression or lymph node involvement, but it exhibited a trend for correlation with increasing tumor stages (p=0.085), and the presence of erbB2 mRNA in the plasma was significantly associated with negative estrogen receptor (ER) and progesterone receptor (PR) status of the primary tumors (p=0.031 and 0.026, respectively). Furthermore, in a small subset of 36 breast cancer patients we found the presence of plasma erbB2 mRNA was significantly correlated with the occurrence of circulating tumor cells (p=0.01). Our study suggests that breast cancer patients with the presence of erbB2 mRNA in the plasma may have a high malignancy or an aggressive phenotype, and frequently detecting plasma erbB2 mRNA may provide a novel approach for monitoring breast cancer progression or response to treatment.

语种英语
WOS记录号WOS:000237645900007
引用统计
被引频次:12[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/66986
专题北京大学临床肿瘤学院
作者单位1.Peking Univ, Beijing Canc Hosp, Sch Oncol, Breast Ctr, Beijing 100036, Peoples R China
2.Peking Univ, Sch Oncol, Beijing Inst Canc Res, Beijing, Peoples R China
3.Karolinska Hosp, Dept Oncol & Pathol, Stockholm, Sweden
推荐引用方式
GB/T 7714
Xu, Y,Yao, LH,Li, HX,et al. Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status[J]. BREAST CANCER RESEARCH AND TREATMENT,2006,97(1):49-55.
APA Xu, Y.,Yao, LH.,Li, HX.,Tao, OY.,Li, JF.,...&Xie, YT.(2006).Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.BREAST CANCER RESEARCH AND TREATMENT,97(1),49-55.
MLA Xu, Y,et al."Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status".BREAST CANCER RESEARCH AND TREATMENT 97.1(2006):49-55.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Xu, Y]的文章
[Yao, LH]的文章
[Li, HX]的文章
百度学术
百度学术中相似的文章
[Xu, Y]的文章
[Yao, LH]的文章
[Li, HX]的文章
必应学术
必应学术中相似的文章
[Xu, Y]的文章
[Yao, LH]的文章
[Li, HX]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。